Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Renovaro Inc (RENB)

Renovaro Inc (RENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Renovaro Inc 2080 Century Park East Suite 906 Los Angeles CA 90067 USA

www.renovarobio.com P: 305-918-1980

Description:

Renovaro Inc. includes RenovaroCube and Renovaro Biosciences. Renovaro Biosciences is an advanced cell-gene-immunotherapy company. Its lead candidate product is a therapeutic vaccine targeting cancers which are difficult to treat including pancreatic and potentially HNC, triple-negative breast cancer, and advanced liver cancer. Renovaro Inc., formerly known as Renovaro Biosciences Inc., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 143,080
Enterprise Value, $K 141,210
Shares Outstanding, K 147,505
Annual Sales, $ 0 K
Annual Net Income, $ -39,680 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -17,020 K
EBIT, $ -25,790 K
EBITDA, $ -6,370 K
60-Month Beta 0.44
% of Insider Shareholders 21.72%
% of Institutional Shareholders 71.41%
Float, K 115,467
% Float 78.28%
Short Volume Ratio 0.78

Growth:

1-Year Return -4.95%
3-Year Return -76.17%
5-Year Return -85.37%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -69.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 05/15/24
Next Earnings Date 05/17/24
Earnings Per Share ttm -0.70
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RENB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -59.59%
Return-on-Assets % -47.14%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.78
Book Value/Share 1.17
Interest Coverage -67.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar